1. Medtech Insight
  2. >>Policy & Regulation

Medtronic’s Hugo Soft-Tissue Robot Expands Into EU, Canada And Japan

 
• By Marion Webb

Medtronic announced on 19 October its robotic-assisted system Hugo has gained regulatory approvals in Japan, the third largest robotics market worldwide, and general surgery approval in the EU and Canada. A surgeon offered perspectives on Hugo versus Intuitive Surgical’s da Vinci surgical robot.

• Source: Medtronic PLC

Medtronic plc received three significant regulatory approvals for its Hugo robotic-assisted surgery (RAS) system, expanding access into Europe, Canada and Japan, the company announced on 19 October.

Medtronic announced that Hugo RAS, which is a modular, multi-quadrant platform designed for a broad range of soft-tissue procedures, received the CE mark for general surgery in Europe, expanding on...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Approvals

More from Policy & Regulation

Inclusive By Design: UK Invites Sponsors To Submit Trial Diversity Plans

 
• By Vibha Sharma

The UK has issued clearer guidance to help drug and medical device sponsors demonstrate how they intend to include a diverse and relevant range of participants in their clinical trials.

Plans For Specific EU Orphan And Pediatric Device Expert Panel Need To Go Further

 
• By Amanda Maxwell

Moves are at last underway for a more specific focus on orphan and pediatric devices. They are a start; but experts are calling for more to support this sector.

First Alzheimer’s Disease Diagnostic Blood Test Cleared By FDA

 
• By Natasha Barrow

Fujirebio Diagnostics' Alzheimer's disease test, Lumipulse G pTau217/ß-Amyloid 1-42 Plasma Ratio, has been cleared by the US FDA.